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Abstract 
Early human post-implantation development involves extensive growth combined with a series of 
complex morphogenetic events. The lack of precise spatial and temporal control over these processes 
leads to pregnancy loss. Given the ethical and technical limitations in studying the natural human 
embryo, alternative approaches are needed to investigate mechanisms underlying this critical stage of 
human development. Here, we present an overview of the different stem cells and stem cell-derived 
models which serve as useful, albeit imperfect, tools in understanding human embryogenesis. Current 
models include stem cells that represent each of the three earliest lineages: human embryonic stem 
cells corresponding to the epiblast, hypoblast-like stem cells and trophoblast stem cells. We also review 
the use of human embryonic stem cells to model complex aspects of epiblast morphogenesis and 
differentiation. Additionally, we propose that the combination of both embryonic and extra-embryonic 
stem cells to form three-dimensional embryo models will provide valuable insights into cell-cell chemical 
and mechanical interactions that are essential for natural embryogenesis. 
 
Introduction  
Human embryo development has been a topic of great interest for millennia, yet much of our 
knowledge comes from the study of mouse embryogenesis and non-human primates due to limitations 
in studying human embryos. Nevertheless, following successful human oocyte fertilization and 
subsequent development ex vivo1, we have a basic picture of human embryology until day 7 post-
fertilization2. More recently, the development of new culture methods has allowed us to expand our 
knowledge of human development up to day 13/143–5, the legal limit of human embryo culture. 
During the first 7 days of development, the embryo develops from a fertilized zygote to a blastocyst 
comprised of the epiblast (precursor to the embryo proper), the hypoblast (precursor to the yolk sac) 
and the trophectoderm (precursor to the embryonic portion of the placenta)6–8 (Fig.1). During the 
second week of development, the blastocyst implants into the maternal uterus via the trophectoderm 
and undergoes subsequent complex morphogenetic events. This includes the polarization of the 
epiblast to form a central lumen (precursor to the amniotic cavity), formation of the amniotic epithelium 
(together with future amniotic mesoderm will form amniotic sac membrane), and possibly the 








unknown9–11. Further, extra-embryonic mesenchyme cells emerge, possibly from the hypoblast, and fill 
the luminal space between the trophoblast and other lineages5,9,12. On day 13/14, the primitive streak 
will form at the posterior of the epiblast, giving rise to the formation of three germ layers of the embryo 
proper. In-depth descriptions of human embryo development during these stages are reviewed 
elsewhere2,8. 
Many questions remain unanswered concerning these first 14 days of human embryo development. For 
example, what is the role and function of the key transcription factors that underlie lineage segregation? 
How is the amniotic epithelium specified? What is the origin of PGCs in the human embryo? Is human 
epiblast pre-patterned to specify the anterior-posterior axis prior to gastrulation? The ability to achieve 
molecular and mechanistic understanding of human development is limited when using natural human 
embryos due to the technical and ethical barriers in using genetic tools. Additionally, many donated 
embryos from patients undergoing in vitro fertilization treatment may harbor chromosomal 
translocations, aneuploidies, or harmful mutations13. Thus, an alternative approach is needed. While 
some insights have been gleaned from non-human primates, strong ethical limitations still exist while 
conservation of gene function and related mechanisms with the human context is not guaranteed. 
Further, in-depth mechanistic understanding is aided by the use of simplified models. Here, we discuss 
how stem cells resembling the first three lineages will provide promising complementary tools to model 
aspects of pre-gastrulation human development and dissect their inner-workings.  
 
Human Stem Cells: Simple Models of Individual Tissu es 
Stem cells cultured under conventional conditions are, themselves, simple models of different tissues of 
the embryo. Using genetic perturbation, reporter assays that allow for the visualization of gene 
expression and signaling dynamics, and small molecule screens, stem cells can provide valuable 
insights into the mechanisms underlying their identity maintenance, differentiation potential, signaling 
dynamics and more. However, it has proven challenging to benchmark different stem cells against the 
embryo to understand how accurately, and at what stage, they recapitulate their respective tissues. 
Here we will discuss the derivation of different stem cells and their recapitulation of specific tissues in 
the early post-implantation human embryo.  
Human Embryonic Stem Cells 
Human embryonic stem cells (hESCs) which can be cultured in vitro indefinitely and retain key epiblast 
marker expression, such as the transcription factors OCT4 and SOX2, were first derived from the 
blastocyst-stage epiblast in 199814. Conventionally, hESCs are cultured in media including factors that 
activate FGF and TGFB/Activin A signaling pathways. Overexpression of key epiblast genes in adult 
somatic cells also resulted in reprogrammed cells with hESC-like identities (human induced pluripotent 
stem cells; hiPSCs), which can also be propagated in FGF/ActivinA conditions15–17. Following their 
derivation, hESCs have become a valuable tool in understanding stem cell differentiation, and their 
clinical applications are expanding18. hESCs are also a valuable model to study pluripotency and 
differentiation potential, providing a useful tool in both modeling disease and investigating aspects of 
the human epiblast. 
hESCs have been validated in their ability to give rise to cells derived from all three germ layers19,20. 
The potency of hESCs in standard culture conditions does not match that of mouse ESCs (mESCs), 
which exhibit features that more closely recapitulate a “naïve” state of pluripotency of the pre-









implantation epiblast and display higher levels of DNA methylation, expression of primed markers such 
as the signaling factor FGF2, and less compact cell colony morphology. Thus, many groups sought to 
capture the earlier, naïve pluripotency state exhibited by the blastocyst epiblast which is characterized 
by decreased DNA methylation and expression of distinct markers such as KLF4, Xist (representing the 
initiation of X-chromosome silencing in XX embryos) and certain transposable elements21–24. Many 
protocols have been developed to generate naïve hESCs (Table 1). Some rely on converting 
conventional, primed hESCs or hiPSCs with small molecules and varied media conditions. These 
conditions commonly involve inhibition of GSK3, ERK, PKC, and Rock pathways, LIF supplementation, 
and are sometimes coupled with targeted overexpression of specific proteins. Additionally, naïve 
hESCs can be derived directly from the blastocyst24-35. Each of these protocols results in different 
“naïve” cells, all of which tend to have a transcriptional profile distinct from primed hESCs and an 
increase in global demethylation. However, many lack the transposable elements expression profile 
matching that of the pre-implantation epiblast and instead more closely resemble the morula22. Others 
still seem to be more transcriptionally similar to the post-implantation epiblast rather than pre-
implantation, including “Extended Potential” and “NHSM” cells36.  
Comparative work using naïve hiPSCs derived using different protocols has highlighted differences in 
transcriptional identity, methylation patterns, and chromosomal stability37. Specifically, two types of 
naïve cells showed the most similarity to the human pre-implantation epiblast both transcriptionally and 
epigenetically: 5i/L/A(F)27 cells and Reset (t2iLGö/PXGL) cells28,31,33,37. Naïve cells vary in their capacity 
to respond to germ layer differentiation cues: Reset (t2iLGö/PXGL) cells require “capacitation” while 
other cells, such as the recently reported “HENSM” cells, do not38,39. The distinctions between different 
“naïve” hESCs raise questions about the nature of human naïve pluripotency, and how well these 
different protocols generate cells that recapitulate the pluripotency state of the pre-implantation 
epiblast. Limitations in using hESCs as a model of the epiblast also include variation across different 
hESC lines in gene expression levels, epigenetic properties, and more40. While these different cell lines 
are useful in investigating aspects of pluripotency state and differentiation, more robust comparative 
work is needed to understand the nature of pluripotency transitions/states – both in how well different 
hESC types correspond to the epiblast in vivo and how they compare to each other in vitro.  
Human Hypoblast-Like Stem Cells 
While hESCs can be used as a model of the human epiblast, hypoblast-like stem cells are useful in 
modeling the human hypoblast (Table 2). Hypoblast cells emerge from the inner cell mass and give rise 
to the yolk sac. During pre-gastrulation development, the hypoblast cells in contact with the overlying 
epiblast cells form a bilaminar disk. Whether the human hypoblast contains important signaling centers 
involved in signaling to the epiblast and shielding the anterior region from mesendoderm differentiation, 
analogous to the mouse Anterior Visceral Endoderm (AVE)41, remains unknown. Models of human 
hypoblast cells could reveal how this may occur.  
While successful derivation of mouse extraembryonic endoderm cells has been previously achieved42, 
a hypoblast stem cell line has not yet been directly derived from human embryos. Alternatively, 
transcription factor reprogramming approaches applied to hESCs have been promising, albeit with 
some shortcomings (Table 2). It has been reported that constitutive expression of transcription factor 
SOX7 in hESCs leads to differentiation of hypoblast-like progenitors, although, expression of the 
hESC/epiblast markers OCT4 and NANOG was maintained43, suggesting a failure in full trans-
differentiation. Additionally, GATA6 induction in hESCs results in the downregulation of pluripotency 
gene expression and upregulation of hypoblast-associated genes. These cells also exhibit increased 









hypoblast-like lineage commitment. Importantly, overexpression of these hypoblast transcription factors 
results in cell lines that could not self-renew beyond a few passages43,44. More recently, an expandable 
hypoblast-like stem cell line, so-called naïve extra-embryonic endoderm (nEnd), has been derived from 
naïve hESCs through culture with Activin, ChIR99021 and LIF45. Activation of FGF signaling was 
essential in this induction, suggesting a conserved role of this pathway in hypoblast specification, as in 
the mouse46,47. However, studies of the human blastocyst stage embryos indicate that FGF signaling is 
dispensable for hypoblast specification ex vivo48,49, suggesting that nEnd cells may be specified through 
distinct pathways. Nevertheless, transcriptomic analysis showed a strong correlation between nEnd 
and hypoblast of the human blastocyst, suggesting that it might be a promising initial in vitro model 
resembling the in vivo hypoblast45. Markers to distinguish the hypoblast from definitive endoderm, 
which forms following gastrulation, have not been identified in the human embryo, and such markers 
will be essential for evaluation of hypoblast-like cell lines. Direct isolation of hypoblast-like stem cells 
from human embryos still has not been accomplished. 
Human Trophoblast-Like Stem Cells 
The human placenta consists of three major trophoblast cell types: cytotrophoblast (CTB), 
syncytiotrophoblast (STB), and extravillous trophoblast (EVT). Following implantation, cytotrophoblast 
precursor cells expand and differentiate into STB in floating villi or EVT in anchoring villi50. Only in 2018, 
human trophoblast stem cells (hTSCs) were derived from the blastocyst trophectoderm and first-
trimester placental isolates51. Both derivations required culture conditions supporting WNT and EGF 
signaling as well as TGFB, Histone Deacetylase, and Rock inhibition, and both derivations resulted in a 
self-renewing cytotrophoblast-like cell line which can give rise to both STB and EVT.  Molecular, 
transcriptomic, and epigenetic characterizations demonstrate that these hTSCs are similar to both 
primary trophoblast isolates and day 10/12 ex vivo cultured human trophoblast51,52.  
Prior to the derivation of trophoblast cells directly from the embryo, trophoblast-like cells were derived 
by differentiation of hESCs using the signaling factor BMP453–55. Genome-wide expression analysis 
showed a close correlation between the resulting cells and human placental cells54, and they can give 
rise to STB- and EVT-like populations56. Subsequent work demonstrated that the transcription factors 
GATA2, GATA3, TFAP2A, and TFAP2C are part of the network activated in this protocol and that 
GATA3 overexpression in hESCs could mimic BMP4-driven differentiation57. Further characterization 
regarding key hallmarks defining temporally pooled first-trimester trophoblast cells has shown that 
BMP4-differentiated hESCs do not fulfill these criteria58. It has been proposed that these cells may 
actually be extraembryonic mesoderm derivatives59 or amnion-like cells36, or a mixed population. This 
highlights the need for robust characterization of stem cell lines. 
Recently, new methods for differentiating hESCs to trophoblast-like stem cells have emerged. One 
study used chemically defined media to derive two distinct trophoblast-like cells from hESCs: 
transcription factor CDX2-negative, tumor suppressor P63low stem cells equivalent to primary hTSCs, 
and another novel CDX2-positive, P63high putative human trophectoderm stem cell (hTESC), which 
display distinct culture requirements and transcriptome differences compared with hTSCs56,60. Another 
study showed that ERK and TGFB inhibition of naïve hESCs results in differentiation to trophoblast-like 
cells in a BMP-independent manner36. Additionally, culture of naïve hESCs in hTSC media leads to a 
heterogeneous population of trophoblast-like cells, which can be further purified through cell-
sorting29,52,61. In these conditions, conventional primed hESCs were not able to give rise to stable TS-
like cells, but instead produced cells that, based on bioinformatic analysis, may possess amnion-like 
qualities36,52. A comparative analysis of human trophoblast-like cells generated from different protocols 









understanding the extent to which these trophoblast-like cells model the in vivo trophoblast niche. 
Specifically, such an assessment could determine transcriptional similarity to the in vivo niche as well 
as the fulfillment of previously described stringent criteria, including expression of key trophoblast 
markers such as GATA3 and TFAP2C, expression of HLA class I molecules, demethylation of the ELF5 
promoter, and expression of the chromosome 19 miRNA cluster expression58. 
Complex ESC-Derived Models of Early Human Developme nt 
Stem cell lines in conventional two-dimensional (2D) culture are powerful tools for investigating 
properties relevant to the human embryo. However, 2D culture is limited in its ability to recapitulate the 
natural tissue niche, including 3D spatial organization of different cell types, and the localized paracrine 
signaling between different structures and tissues. To better capture these properties, different 
approaches have been developed to model more complex aspects of embryogenesis using hESCs 
(Fig. 2). Here we discuss different hESC-derived models of the embryo, their utility, and their 
limitations. 
Embryoid Bodies and Gastruloids 
Similar to previous work in mESCs, hESCs can be aggregated into 3D structures and cultured in 
conditions permissive for differentiation. The resulting structures (embryoid bodies), demonstrated that 
hESCs can form derivatives of all three germ layers in vitro62. Many methodologies have emerged to 
generate embryoid bodies including aggregation in suspension, hanging drops, microwells, and 
Aggrewells as well as addition of factors promoting survival such as Rock inhibitor63–67. Each of these 
platforms allows for cells to aggregate to each other, rather than attach to the underlying dish as in 
conventional 2D culture conditions. Embryoid bodies offer a 3D model with complex differentiation 
behaviors that are useful in identifying different signaling factors required for differentiation of specific 
cell types, and in examining cellular behaviors key to germ layer differentiation during gastrulation, 
including epithelial-mesenchymal transition (EMT) and cell migration. Embryoid bodies can be induced 
to form a functional gastrula organizer, which drives secondary axis formation when grafted to frog 
embryos68. They are also often a starting point for directed differentiation and formation of complex 
organoids63,69,70. Embryoid bodies represent an opportunity to test the effects of different compounds or 
drugs on 3D structures undergoing cell fate decisions and behaviors reminiscent of the human 
embryo64,66 and to test the potency of stem cells to give rise to specific lineages52. However, they lack a 
controlled organization of differentiation and tissue localization and do not directly model a specific 
stage or morphological structure within the embryo. 
Recently, embryoid bodies treated with GSK-inhibitor CHIR99021 before and after aggregation in low-
adherence plates have demonstrated asymmetric axial elongation over a four-day period71. At the 
elongating tip of these structures, termed gastruloids, markers of the three germ layers (BRA-positive 
(+) mesoderm, SOX17+ endoderm, and SOX2+ ectoderm) are present in distinct regions. Overall, the 
anterior region of gastruloids expresses cardiac development markers, while the most posterior, 
elongating tip resembles the mammalian tailbud. Similar to work with mouse gastruloids, human 
gastruloids represent post-primitive streak structures that include the transcriptional signature of somite 
formation, though they lack gene signatures of anterior structures71. This 3D model, therefore, 
represents stages of human development that lie beyond the legal boundaries of ex vivo culture 
offering an exciting opportunity to investigate transcriptional dynamics, cell differentiation, and signaling 
in the posterior human embryo. Given that no ex vivo confirmation of these events can be achieved in 
the natural embryo, it is not yet possible to know if divergences from model organisms represent bona 









to uncover mechanisms of axial elongation and patterning. Given the presence of a somitogenesis 
gene signature along the anterior-posterior axis, this model may complement existing 2D models to 
understand aspects of somitogenesis including segmentation timing and gene expression patterns72. 
However, these gastruloids do not mimic pre-gastrulation human development or the formation of germ 
cells at gastrulation. 
Micropatterned hESCs 
While hESCs cultured in conventional 2D environment lack defined organization, confinement of 
hESCs on 1000µm-diameter 2D micropatterns and exposure to BMP4 were shown to give rise to 
spatially organized rings of different cell types in a highly reproducible fashion, reminiscent of 
gastrulation73. Specifically, an outer CDX2+, SOX17 and SOX2-negative(-) “extra-embryonic” ring that 
shares characteristics of the trophoblast and amnion74, a SOX17+NANOG+SOX2- “endodermal” ring, a 
BRA+NANOG+SOX17-SOX2- “mesoderm” ring, and a SOX2+NANOG-BRA-SOX17- “ectoderm” 
center73. Additional exposure of these 2D micropatterns to WNT and NODAL signaling drives the 
formation of a human “organizer” that is functional in inducing a secondary body axis when grafted into 
chick embryos75. This highly reproducible model of the germ layers normally established through 
gastrulation is extremely useful for investigating the signaling dynamics, morphogen and receptor 
behaviors, and their effect on cell fate as well as the self-organization potential of stem cells. These 
micropatterned hESCs have been used to demonstrate the complex interplay of BMP, WNT, and 
NODAL signaling dynamics76–79. This entails the exposure of exogenous BMP initially activating WNT 
expression, which in turn activates NODAL. The initial BMP exposure also drives receptor relocalization 
for cells towards the center of the colony, decreasing their sensitivity to BMP signaling, and the 
activation of its own inhibitor, NOGGIN, which also diffuses towards the center, eventually resulting in 
edge-restricted BMP activity that drives the CDX2+ extraembryonic fate. The WNT and NODAL 
signaling domains move as a wave toward the center of the colony, independent of any cell migration. 
The duration of the wave of WNT and NODAL, in addition to the rate of concentration change of 
NODAL, drives primitive streak-like mesendodermal identity, with the NODAL inhibitor CER1 acting 
downstream of WNT to specify endoderm versus mesoderm, and the maintained low levels of WNT at 
the dense colony center promoting ectodermal identity76–80. These discoveries have been possible 
through the use of reporter and knock-out cell lines to demonstrate the role of a given factor, which 
would not be possible in the natural human embryo. While powerful tools in modeling signaling 
dynamics in germ layer differentiation, these micropatterns lack key morphological features of the 
epiblast morphogenesis, such as formation of a central lumen to establish the pro-amniotic cavity and 
EMT to induce gastrulation. 
Spheroids and Post-Implantation Amniotic Sac Embryoids 
It has been demonstrated that hESCs, when exposed to an extracellular matrix, such as Matrigel, 
polarize and form a lumen81,82. The resulting structure is similar to a day 10 human epiblast in cell 
number, size and morphology83. This peri/post-implantation epiblast model has been used to 
investigate the mechanisms behind embryo polarization and lumenogenesis and the coupling of 
changes in the pluripotency state with morphogenesis. It was found that hESCs maintained in naïve 
conditions can polarize but are unable to open a lumen, while naïve cells allowed to undergo 
pluripotency transition undergo lumenogenesis successfully. This process is relevant to in vivo 
development as no embryos cultured in naïve conditions were able to exit naïve pluripotency or open a 
lumen, demonstrating the utility of hESCs to recapitulate key aspects of embryogenesis81 and 
complement work in the human embryo. Moreover, when exposed to a 48-hour pulse of BMP4, these 









domain83. These spheroids provide a model of the peri- and post-implantation epiblast and can 
recapitulate lumenogenesis and at least some aspects of symmetry breaking. However, they are 
relatively stagnant in their developmental potential and do not undergo amnion specification on one 
side of the lumen.  
Additional work has generated hESC-derived models that recapitulate amniogenesis. hESCs cultured 
on a gel matrix, with a softer gel surrounding, were shown to form a squamous cyst of amnion-like 
cells84. At optimized cell density, a small subset of structures formed a cyst with amnion-like cells on 
one side of the lumen and columnar epiblast-like cells on the other85. This post-implantation amniotic 
sac embryoid (PASE) also exhibits EMT events in the columnar compartment such as the upregulation 
of SNAI1, downregulation of E-CADHERIN, and cell migration –  similar to the formation of the primitive 
streak85. PASE formation has been optimized to an impressive extent by the use of microfluidic 
technology and exposure to BMP4 at the “amniotic” pole, providing an improved experimental system86. 
This also leads to the formation of PGC-like cells within the PASE structure and more robust EMT86. An 
anteriorized PASE lacking primitive streak-like formation can be achieved with the introduction of WNT 
and BMP inhibition at the “epiblast” pole86. Further, WNT signaling was shown to be instrumental in the 
inductive ability of amnion-like cells to drive primitive streak-like cell differentiation86. Thus, the PASE 
and its applications demonstrate the potential of hESCs to model the post-implantation, pre-gastrulation 
epiblast. Yet, questions remain of how closely these amnion-like cells resemble the amnion in natural 
embryos as current ex vivo culture systems do not robustly specify amnion, limiting the possibilities for 
an accurate comparison. Overall, the PASE offers a promising platform to investigate aspects of the 
post-implantation development such as amnion formation and its potential inductive roles in primitive 
streak and PGC specification. 
 
Future Perspectives: Inclusion of Extra-embryonic C ells in Human Stem Cell Models 
Thus far, modeling the human embryo with stem cell-derived structures has relied on hESCs cultured in 
the absence of extra-embryonic stem cells. Although cells isolated from first-trimester placentas can 
form 3D placental organoids in vitro87, models of human pre-gastrulation including extra-embryonic 
tissues have not yet been reported. Interestingly, mouse ESCs and TSCs can form structures 
morphologically similar to the post-implantation mouse embryo88. Further addition of mouse extra-
embryonic endoderm stem cells results in improved post-implantation structures89. Also, blastocyst-like 
structures have been derived from mouse ESCs, EpiSCs (primed mouse cells), or ESCs in combination 
with TSCs90–92. Comparisons of human versus mouse stem-cell derived models of development are 
reviewed elsewhere93. 
Given the success of generating more complete stem cell-derived embryo models in the mouse, is it 
possible to build human pre-gastrulation models comprising human epiblast, hypoblast, and 
trophoblast-like lineages (Fig.3)? If these different types of cells can self-organize into structures that 
acquire the embryo’s architecture and molecular features of pre-implantation or post-implantation 
embryos, they would present powerful tools to investigate lineage crosstalk or differential lineage 
response to perturbation difficult to investigate in the natural embryo. This will likely require 
characterization of the different kinds of extra-embryonic stem cells regarding their potential to develop 
with hESCs. The development of stem cell models that include all three cell type precursors to the 
conceptus – the fetus and its supporting tissues – will require a reconsideration of ethical guidelines on 
how to regulate stem cell-based models of the embryo94. Some argue that future models encompassing 









rule as natural human embryos aree94-97. Others argue that given some structures may begin at a stage 
past primitive streak formation, the framework of the 14-day rule is not suitable to address the ethical 
questions raised by stem cell-derived embryo-like structures98 and other facts about these structures 
should be used in ethical argumentation99. The development of ethical guidelines regarding the 
limitations and funding restrictions on related work will be crucial as the field moves closer to 
developing models encompassing all cell types of the early human conceptus. 
 
Conclusion: Synthetic Embryos Rooted in the Natural  Embryo 
It is estimated that 30-60% of pregnancies end in pre-clinical miscarriage during the “black-box” period 
of pre-gastrulation development100,101. In 2016, the “black box” of pre-gastrulation development was 
opened with ex vivo culture of human embryos in pre- and post-implantation stages3,4. By nature, this 
work has been largely descriptive. Recently, the single-cell transcriptional profile of a single gastrulating 
human embryo has been reported102. This resource, along with other profiles of ex vivo cultured 
embryos5,7,103, will provide a transcriptional blueprint for the stem cell-based models leading to and 
encompassing gastrulation-like events. They provide opportunities to identify markers for hypoblast 
versus definitive endoderm, as well as other tissues. Using the natural embryo as a guide, stem cells 
offer remarkable opportunities to dissect molecular and signaling events, both within and between 
tissues, and interrogate the importance of different factors which is exceedingly difficult to determine in 
vivo. This includes understanding molecular mechanisms104, self-organization principles105,106, tissue 
mechanics and mechanobiology107, and signaling activity108. Thus, models of human development will 
begin to elucidate why pregnancies fail at such high rates during this period.  
Aneuploidy is thought to be a major cause of pregnancy loss, and a recent study has characterized the 
developmental potential of embryos harboring specific chromosome aneuploidies109. Single-cell RNA-
sequencing studies have highlighted that the rate of aneuploidy in mosaic embryos is higher in the 
trophoblast compared to the epiblast during post-implantation, despite no difference during pre-
implantation110, raising the question if aneuploid cells are preferentially depleted in the epiblast as in 
mouse models of mosaic aneuploidy111,112. Building stem cell models including aneuploid embryonic 
and extra-embryonic stem cells will be useful in investigating mechanisms underlying phenotypes 
associated with specific aneuploidies, and the behavior of euploid versus aneuploid cells in a mosaic 
context. Also, the susceptibility of the embryo to novel pathogens – such as SARS-CoV-2 virus – could 
be further investigated in vitro113. 
The development of novel stem cell-based models of the embryo provides a simplified system with 
which we can understand complex processes underlying the beginning of our lives. Each model 
provides unique insights and opportunities, and continued work will expand our tools and knowledge to 
illuminate the mysterious black box of human development. 
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Figure 1: Pre-Gastrulation Development of the Human  Embryo.  Following fertilization, the zygote 
undergoes a series of cleavage stages. Between the 4- and 8-cell stage, embryonic genome activation 
(EGA) occurs114. At the 8-to-16-cell stage the embryo compacts and undergoes polarization115, and 
subsequently the morula forms in which the outside cells will give rise to the trophectoderm and the 
inside to the inner cell mass. At day 5 the embryo reaches the blastocyst stage36,116, and at the late 
blastocyst stage the epiblast, hypoblast, and trophoblast cells have undergone lineage commitment6–8. 
The mature blastocyst then implants in the maternal uterus, and the epiblast exits pluripotency and 
undergoes lumenogenesis to form the amniotic cavity. Meanwhile, the hypoblast proliferates and 
begins to form the visceral endoderm surrounding the yolk sac cavity. The epiblast cells in contact with 
the overlying trophoblast give rise to the amnion while the cells in contact with the hypoblast will go on 
to form the embryo proper. The trophectoderm gives rise to cytotrophoblast and multinucleated 
syncytiotrophoblast which will in turn generate the embryonic portion of the placenta. On day 13/14 it is 
thought that PGCs are specified, extraembryonic mesenchyme has formed, and that the primitive 
streak forms at the posterior epiblast. ICM, Inner Cell Mass; EPI, Epiblast; HYPO, Hypoblast; TE, 
Trophectoderm; PGCs, Primordial Germ Cells. 
Figure 2: Derivation of Human Stem Cells and Embryo nic Stem Cell Models. Human embryonic 
stem cells (hESCs) and human trophoblast stem cells (hTSCs) have been derived directly from the 
human blastocyst while hypoblast-like cells (HBLCs) can be derived from naïve hESCs. Naïve hESCs 
can also give rise to trophoblast-like cells. hESCs can be used to form embryoid bodies and 
gastruloids, micropatterned hESC cultures, spheroids and post-implantation amniotic sac embryoids 
(PASE). Each can be used to investigate specific aspects of embryogenesis. 
Figure 3: Theoretical Stem Cell Models with Embryon ic and Extra-Embryonic Stem Cells.  
Embryonic, trophoblast, and hypoblast-like (hESC, hTSC, HBLCs) cells may be co-cultured to form 
either blastocyst or post-implantation-like structures containing both embryonic and extraembryonic 
cells. Ideally, these models would be able to mature and undergo transitions between stages that 










Table 1: Naïve hESC Protocols 
Paper Cell Name Overexpression Small Molecules Source 
Hanna et al., 
2010 





Gafni et al., 
2013 
NHSM (basis for 
commercially 
available Rset) 
N/A PD0325901, CHIR99021, 




Chan et al., 
2013 
3iL N/A PD0325901, BIO, 
Dorsomorphin, LIF 
hESCs 
Ware et al., 
2014 





et al., 2014 
5i/L/A N/A PD0325901, IM-12, 
SB590885 
WH-4-023, Y-27632, LIF, 
Activin A 
hESCs 
Qin et al., 
2016 




et al., 2016 
Reset (hESC) NANOG, KLF2 PD0325901, CHIR99021, 
LIF, Gö6983 (t2iLGö) 
hESCs 
Guo et al., 
2016 
Reset (Blastocyst) N/A t2iLGö Blastocyst 
ICM 
Yang et al., 
2017 









N/A PD0325901, LIF, VPA, 
Sodium butyrate  
PD0325901, LIF, Gö6983  
t2iLGö 
hESCs 




N/A CHIR99021, A419259, 
XAV939, IWR, vitaminC, LIF 
hESCs 
Bayerl et al., 
2020 





















Table 2: Protocols for Derivation of Extra-Embryoni c Stem Cell Types 
Paper Model Overexpression Small Molecules  Source 




SOX7 N/A Conventional 
hESCs 





GATA6 N/A Conventional 
hESCs 
Linneberg-
Agerholm et al., 
2019 










Xu et al., 2002; 
Amita et al., 
2013; Li et al., 






N/A BMP4 Conventional 
hESCs 





GATA3 N/A Conventional 
hESCs 




N/A EGF, CHIR99021, 
A83-01, SB431542, Y-












N/A BMP4, SB431542, 
CYM5541    
CYM5541, A83-01, 
FGF10, CHIR99021 
(hTESCs) or Okae et 




Guo et al., 2020 Converted TS-
like (MEK/ERKi) 
(trophoblast-like) 









like (Okae et al., 
2018 media) 
(trophoblast-like) 
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• Human stem cells are complementary tools to study early embryogenesis 
• Embryonic stem cells can mimic aspects of epiblast development 
• 3D culture of embryonic stem cells recapitulates aspects of epiblast morphology 
• Prospect of combining embryonic & extra-embryonic stem cells to model early 
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